Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Alkermes plc. (ALKS)
|
Add to portfolio |
|
|
|
| Price: |
$46.71
| | Metrics |
| OS: |
164.3
|
M
| |
-9
|
% ROE
|
| Market cap: |
$7.67
|
B
| |
-7
|
% ROIC
|
|
Net cash:
|
$467
|
M
| |
$2.84
|
per share
|
|
EV:
|
$7.21
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($30.9)
|
M
| |
|
|
|
EBIT
|
($99.7)
|
M
| |
|
|
| EPS |
($0.58)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 1,173.8 | 1,038.8 | 1,170.9 | 1,094.3 | 903.4 | 745.7 | 628.3 | 618.8 |
| Revenue growth | 13.0% | -11.3% | 7.0% | 21.1% | 21.1% | 18.7% | 1.5% | |
| Cost of goods sold | 197.4 | 178.3 | 180.4 | 176.4 | 154.7 | 132.1 | 139.0 | 175.8 |
| Gross profit | 976.4 | 860.4 | 990.6 | 917.9 | 748.6 | 613.6 | 489.3 | 443.0 |
| Gross margin | 83.2% | 82.8% | 84.6% | 83.9% | 82.9% | 82.3% | 77.9% | 71.6% |
| Selling, general and administrative | 561.0 | 538.8 | 599.4 | 526.4 | 421.6 | 374.1 | 311.6 | 199.9 |
| Research and development | 406.5 | 394.6 | 512.8 | 425.4 | 412.9 | 387.1 | 344.4 | 272.0 |
| EBITA | 10.2 | -68.9 | -133.7 | -53.6 | -64.2 | -139.8 | -159.3 | -29.0 |
| EBITA margin | 0.9% | -6.6% | -11.4% | -4.9% | -7.1% | -18.7% | -25.3% | -4.7% |
| Amortization of intangibles | 38.1 | 39.5 | 40.4 | 65.2 | 62.1 | 61.0 | 57.7 | 58.2 |
| EBIT | -28.0 | -108.4 | -174.1 | -118.7 | -126.3 | -200.8 | -217.0 | -87.1 |
| EBIT margin | -2.4% | -10.4% | -14.9% | -10.8% | -14.0% | -26.9% | -34.5% | -14.1% |
| Pre-tax income | -39.3 | -96.5 | -197.1 | -127.0 | -143.3 | -214.4 | -224.0 | -14.0 |
| Income taxes | 8.9 | 14.3 | -0.4 | 12.3 | 14.7 | -5.9 | 3.2 | 16.0 |
| Tax rate | | | 0.2% | | | 2.8% | | |
| Net income | -48.2 | -110.9 | -196.6 | -139.3 | -157.9 | -208.4 | -227.2 | -30.1 |
| Net margin | -4.1% | -10.7% | -16.8% | -12.7% | -17.5% | -28.0% | -36.2% | -4.9% |
| |
| Diluted EPS | ($0.30) | ($0.70) | ($1.25) | ($0.90) | ($1.03) | ($1.38) | ($1.52) | ($0.21) |
| Shares outstanding (diluted) | 160.9 | 158.8 | 157.1 | 155.1 | 153.4 | 151.5 | 149.2 | 145.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|